Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Debt (2022 - 2025)

Historic Total Debt for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $6.9 million.

  • PAVmed's Total Debt changed N/A to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year change of. This contributed to the annual value of $29.1 million for FY2024, which is 3416.29% down from last year.
  • Latest data reveals that PAVmed reported Total Debt of $6.9 million as of Q3 2025.
  • PAVmed's 5-year Total Debt high stood at $45.5 million for Q1 2024, and its period low was $6.6 million during Q1 2025.
  • Moreover, its 4-year median value for Total Debt was $34.6 million (2022), whereas its average is $30.3 million.
  • As far as peak fluctuations go, PAVmed's Total Debt surged by 4572.88% in 2023, and later plummeted by 8550.72% in 2025.
  • Over the past 4 years, PAVmed's Total Debt (Quarter) stood at $33.6 million in 2022, then skyrocketed by 31.35% to $44.2 million in 2023, then tumbled by 34.16% to $29.1 million in 2024, then crashed by 76.29% to $6.9 million in 2025.
  • Its Total Debt stands at $6.9 million for Q3 2025, versus $6.8 million for Q2 2025 and $6.6 million for Q1 2025.